Literature DB >> 10700566

The effect of delta-9-tetrahydrocannabinol on forebrain ischemia in rat.

D F Louw1, F W Yang, G R Sutherland.   

Abstract

The purpose of the study was to evaluate the effect of delta-9-tetrahydrocannabinol (THC), the major psychoactive constituent of marijuana, on ischemic neuronal injury. A 12-min ischemic insult was induced by a reduction in systolic blood pressure to a mean of 50 mm Hg, followed by bilateral carotid artery occlusion at a middle ear temperature of 37.5 degrees C. THC at either a low (0.1 mg/kg; n=8) or high (10 mg/kg; n=8) dose was injected i.p. every 12 h for 7 days prior to ischemia. Non-treated ischemic (n=8) animals formed the control group. The animals were sacrificed 3 weeks post-ischemia for quantitative histopathology. THC at either dose did not significantly reduce ischemic neuronal damage in the hippocampus. The high dose THC-treated group showed significantly less neocortical injury, compared to either the control or low-dose THC groups (p<0.05). The striatum was markedly protected by both low and high dose THC (p<0.001). This regionally specific protection implies that either the hippocampus undergoes suprathreshold ischemic injury or that mechanisms of ischemic injury vary in different brain regions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10700566     DOI: 10.1016/s0006-8993(99)02422-1

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  20 in total

Review 1.  Endocannabinoids and cannabinoid receptors in ischaemia-reperfusion injury and preconditioning.

Authors:  P Pacher; G Haskó
Journal:  Br J Pharmacol       Date:  2007-11-19       Impact factor: 8.739

2.  Exogenous anandamide protects rat brain against acute neuronal injury in vivo.

Authors:  M van der Stelt; W B Veldhuis; G W van Haaften; F Fezza; T Bisogno; P R Bar; G A Veldink; J F Vliegenthart; V Di Marzo; K Nicolay
Journal:  J Neurosci       Date:  2001-11-15       Impact factor: 6.167

3.  Aversive effects of ethanol in adolescent versus adult rats: potential causes and implication for future drinking.

Authors:  Nicole L Schramm-Sapyta; Alexandra G DiFeliceantonio; Ethan Foscue; Susan Glowacz; Naadeyah Haseeb; Nancy Wang; Cathy Zhou; Cynthia M Kuhn
Journal:  Alcohol Clin Exp Res       Date:  2010-09-22       Impact factor: 3.455

Review 4.  The endocannabinoid system as an emerging target of pharmacotherapy.

Authors:  Pál Pacher; Sándor Bátkai; George Kunos
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

Review 5.  Acute neuronal injury, excitotoxicity, and the endocannabinoid system.

Authors:  Mario van der Stelt; Wouter B Veldhuis; Mauro Maccarrone; Peter R Bär; Klaas Nicolay; Gerrit A Veldink; Vincenzo Di Marzo; Johannes F G Vliegenthart
Journal:  Mol Neurobiol       Date:  2002 Oct-Dec       Impact factor: 5.590

Review 6.  Biosynthesis of endocannabinoids and their modes of action in neurodegenerative diseases.

Authors:  Mario van der Stelt; Henrik H Hansen; Wouter B Veldhuis; Peter R Bär; Klaas Nicolay; Gerrit A Veldink; Johannes F G Vliegenthart; Harald S Hansen
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

7.  Brain levels of N-acylethanolamine phospholipids in mice during pentylenetetrazol-induced seizure.

Authors:  Birthe Moesgaard; Henrik H Hansen; Suzanne L Hansen; Steen Honore Hansen; Gitte Petersen; Harald S Hansen
Journal:  Lipids       Date:  2003-04       Impact factor: 1.880

Review 8.  Role of cannabinoids and endocannabinoids in cerebral ischemia.

Authors:  Cecilia J Hillard
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

9.  Neuroprotective effect of (-)Delta9-tetrahydrocannabinol and cannabidiol in N-methyl-D-aspartate-induced retinal neurotoxicity: involvement of peroxynitrite.

Authors:  Azza B El-Remessy; Ibrahim E Khalil; Suraporn Matragoon; Gamal Abou-Mohamed; Nai-Jer Tsai; Penny Roon; Ruth B Caldwell; Robert W Caldwell; Keith Green; Gregory I Liou
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307

10.  Delta9-tetrahydrocannabinol (THC) and AM 404 protect against cerebral ischaemia in gerbils through a mechanism involving cannabinoid and opioid receptors.

Authors:  A Zani; D Braida; V Capurro; M Sala
Journal:  Br J Pharmacol       Date:  2007-10-29       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.